IBDEI310 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,48321,0)
 ;;=N36.9^^185^2420^107
 ;;^UTILITY(U,$J,358.3,48321,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48321,1,3,0)
 ;;=3^Urethral Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,48321,1,4,0)
 ;;=4^N36.9
 ;;^UTILITY(U,$J,358.3,48321,2)
 ;;=^5015677
 ;;^UTILITY(U,$J,358.3,48322,0)
 ;;=N34.1^^185^2420^111
 ;;^UTILITY(U,$J,358.3,48322,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48322,1,3,0)
 ;;=3^Urethritis,Nonspecific
 ;;^UTILITY(U,$J,358.3,48322,1,4,0)
 ;;=4^N34.1
 ;;^UTILITY(U,$J,358.3,48322,2)
 ;;=^5015655
 ;;^UTILITY(U,$J,358.3,48323,0)
 ;;=N34.3^^185^2420^110
 ;;^UTILITY(U,$J,358.3,48323,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48323,1,3,0)
 ;;=3^Urethral Syndrome,Unspec
 ;;^UTILITY(U,$J,358.3,48323,1,4,0)
 ;;=4^N34.3
 ;;^UTILITY(U,$J,358.3,48323,2)
 ;;=^5015656
 ;;^UTILITY(U,$J,358.3,48324,0)
 ;;=Z87.442^^185^2420^78
 ;;^UTILITY(U,$J,358.3,48324,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48324,1,3,0)
 ;;=3^Personal Hx of Urinary Calculi
 ;;^UTILITY(U,$J,358.3,48324,1,4,0)
 ;;=4^Z87.442
 ;;^UTILITY(U,$J,358.3,48324,2)
 ;;=^5063497
 ;;^UTILITY(U,$J,358.3,48325,0)
 ;;=R35.0^^185^2420^113
 ;;^UTILITY(U,$J,358.3,48325,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48325,1,3,0)
 ;;=3^Urinary Frequency
 ;;^UTILITY(U,$J,358.3,48325,1,4,0)
 ;;=4^R35.0
 ;;^UTILITY(U,$J,358.3,48325,2)
 ;;=^5019334
 ;;^UTILITY(U,$J,358.3,48326,0)
 ;;=N39.42^^185^2420^114
 ;;^UTILITY(U,$J,358.3,48326,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48326,1,3,0)
 ;;=3^Urinary Incontinence w/o Sensory Awareness
 ;;^UTILITY(U,$J,358.3,48326,1,4,0)
 ;;=4^N39.42
 ;;^UTILITY(U,$J,358.3,48326,2)
 ;;=^5015681
 ;;^UTILITY(U,$J,358.3,48327,0)
 ;;=N39.45^^185^2420^115
 ;;^UTILITY(U,$J,358.3,48327,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48327,1,3,0)
 ;;=3^Urinary Incontinence,Continuous Leakage
 ;;^UTILITY(U,$J,358.3,48327,1,4,0)
 ;;=4^N39.45
 ;;^UTILITY(U,$J,358.3,48327,2)
 ;;=^5015684
 ;;^UTILITY(U,$J,358.3,48328,0)
 ;;=R39.81^^185^2420^116
 ;;^UTILITY(U,$J,358.3,48328,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48328,1,3,0)
 ;;=3^Urinary Incontinence,Functional
 ;;^UTILITY(U,$J,358.3,48328,1,4,0)
 ;;=4^R39.81
 ;;^UTILITY(U,$J,358.3,48328,2)
 ;;=^5019349
 ;;^UTILITY(U,$J,358.3,48329,0)
 ;;=N39.46^^185^2420^117
 ;;^UTILITY(U,$J,358.3,48329,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48329,1,3,0)
 ;;=3^Urinary Incontinence,Mixed,Male/Female
 ;;^UTILITY(U,$J,358.3,48329,1,4,0)
 ;;=4^N39.46
 ;;^UTILITY(U,$J,358.3,48329,2)
 ;;=^5015685
 ;;^UTILITY(U,$J,358.3,48330,0)
 ;;=N39.44^^185^2420^118
 ;;^UTILITY(U,$J,358.3,48330,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48330,1,3,0)
 ;;=3^Urinary Incontinence,Nocturnal Enuresis
 ;;^UTILITY(U,$J,358.3,48330,1,4,0)
 ;;=4^N39.44
 ;;^UTILITY(U,$J,358.3,48330,2)
 ;;=^5015683
 ;;^UTILITY(U,$J,358.3,48331,0)
 ;;=N39.498^^185^2420^119
 ;;^UTILITY(U,$J,358.3,48331,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48331,1,3,0)
 ;;=3^Urinary Incontinence,Other
 ;;^UTILITY(U,$J,358.3,48331,1,4,0)
 ;;=4^N39.498
 ;;^UTILITY(U,$J,358.3,48331,2)
 ;;=^5015686
 ;;^UTILITY(U,$J,358.3,48332,0)
 ;;=N39.490^^185^2420^120
 ;;^UTILITY(U,$J,358.3,48332,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48332,1,3,0)
 ;;=3^Urinary Incontinence,Overflow
 ;;^UTILITY(U,$J,358.3,48332,1,4,0)
 ;;=4^N39.490
 ;;^UTILITY(U,$J,358.3,48332,2)
 ;;=^331569
 ;;^UTILITY(U,$J,358.3,48333,0)
 ;;=N39.43^^185^2420^121
